• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

National Surveillance for Unknown Transfusion-Transmitted Infections

March 13, 2024

The prevention of transfusion-transmitted infections (TTI) is largely based on recruiting donors at low risk of being infected with a TTI and using screening assays to identify known pathogens. However, a small, ever-present risk of transfusion-transmission of unknown pathogens or those with long incubation times remains. To investigate the risk of unknown TTI, researchers in Sweden developed a two-pronged algorithm to search a nationwide Swedish transfusion database (SCANDAT-3S) for concordance for 1155 disease entities between donors and recipients using a series of retrospective cohort analyses.  From 1968-2017, 1.72 million patients (56% female; mean age of first transfusion, 65 years) received 18.97 million blood components (RBCs, plasma, platelet or whole blood units) from 1.04 million blood donors. Based on a median follow-up period of 4.5 years for recipients and 18.5 years for donors, researchers found evidence of 15 diseases caused by a TTI, 13 of which were validated by a second approach based on possible shared diseases among all recipients of a given donor.  While some of the transfusion-transmitted diseases found were expected such as HIV (before 1985) and viral hepatitis, others such as pneumonia, sepsis, gastroenteritis, and colitis of unknown origin require further investigation.  No strong evidence for any unknown TTI were found in Sweden, and this study serves as a proof-of-concept that nationwide databases can be used as a surveillance system for unknown TTI.

Reference:

Dahlen T, Jingchen Z, Busch MP, and G Edgren.  Using routine health-care data to search for unknown transfusion-transmitted disease:  a nationwide, agnostic retrospective cohort study.  The Lancet Digital Health 2024 (6); e105-3113. 

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • Wide Variations in Treatments and Outcomes Globally in Hemolytic Disease of the Fetus and Newborn

  • Tranexamic Acid Treatment Does Not Reduce Hematoma Growth in Patients with Intracerebral Hemorrhage

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Influence of Transfusion Recipient and Donor Traits in Patients with Sickle Cell Disease

  • Pre-Hospital Resuscitation with Low-Titer Type O Whole Blood for Trauma Patients

  • Double-knotting Blood Storage Bag Tubing Reduces Contamination

  • Costs of Type & Screen and Crossmatch Laboratory Tests for RBCs Higher in U.S. Compared to U.K.

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley